Hepatocellular adenoma: Difference between revisions

Jump to navigation Jump to search
Line 28: Line 28:


==[[Hepatocellular adenoma causes|Causes]]==
==[[Hepatocellular adenoma causes|Causes]]==
====Drud Side Effect====
[[Drospirenone and Ethinyl estradiol]],
[[Norethindrone acetate and Ethinyl estradiol]],
[[Norgestimate and Ethinyl estradiol]]


==[[Hepatocellular adenoma epidemiology and demographics|Epidemiology and Demographics]]==
==[[Hepatocellular adenoma epidemiology and demographics|Epidemiology and Demographics]]==

Revision as of 13:32, 24 October 2014

For patient information, click here

Hepatocellular adenoma
MRI: T2 Fat sat. A patient with multiple adenoma.
Image courtesy of RadsWiki
ICD-O: Template:ICDO
DiseasesDB 5726
MeSH D018248

Hepatocellular adenoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hepatocellular adenoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hepatocellular adenoma On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hepatocellular adenoma

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hepatocellular adenoma

CDC on Hepatocellular adenoma

Hepatocellular adenoma in the news

Blogs on Hepatocellular adenoma

Directions to Hospitals Treating Hepatocellular adenoma

Risk calculators and risk factors for Hepatocellular adenoma

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., PhD.

Synonyms and keywords: Hepadenoma; hepatic adenoma

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Drud Side Effect

Drospirenone and Ethinyl estradiol, Norethindrone acetate and Ethinyl estradiol, Norgestimate and Ethinyl estradiol

Epidemiology and Demographics

Risk Factors

Screening

Differentiating Hepatocellular adenoma from other Diseases

Natural History, Complications and Prognosis

Diagnosis

Staging | History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies


Contraindicated medications

Hepatic adenoma is considered an absolute contraindication to the use of the following medications:

Template:Epithelial neoplasms


Template:WikiDoc Sources